Background: Blood transfusion is a traditional treatment for β-thalassemia (β-thal) that
improves the patients' anemia and lifespan, but it may lead to iron overload in parenchymal …

Background. Endocrinopathies are common in patients with β‐thalassemia major despite
parenteral iron chelation therapy with deferoxamine. Prevalence of abnormal glucose …

Objective. To assess body composition in adult male and female patients with thalassemia
major by dual‐energy X‐ray absorptiometry (DXA) and to compare the findings with a group …

Purpose Prevalence of osteoporosis reported as high as 50% in thalassemia major patients.
We compared bone density (BMD) of our patients with results of bone densitometry of …

Background: Beta-thalassemia major patients frequently have endocrinopathies. We tried to
determine relation between demographic and transfusion factor and endocrinopathies …

Background: The prevalence of short stature was reported high in thalassemia major
patients. It causes mental and social problems for them. As different cut-off points for growth …

Purpose: Chronological and longitudinal changes of bone density in patients with secondary
osteoporosis, have been shown helpful in providing a model of calcium and bone …

Background: Beta thalassemia major (BTM) and its treatment by hematopoietic stem cell
transplantation (HSCT) may have deleterious effects on the endocrine systems. We …

Περίληψη Οι ασθενείς με θαλασσαιμία εμφανίζουν μια πολυπαραγοντική διαταραχή των
οστών με προεξάρχουσα αιτία την υπερπλασία του ερυθρού μυελού που καταλαμβάνει τις …

Puji syukur Penulis sampaikan kepada Allah Subhanahu wa Ta'alaa atas rahmat dan
karuniaNya sehingga karya tulis akhir dengan judul “Glycated albumin sebagai deteksi awal …